Home/ Stocks/ DERM

Journey Medical Corporation Common Stock

DERM XNAS

$6.91 +0.01 (+0.14%) ▲ 15-min delayed

Open

$6.83

High

$7.04

Low

$6.56

Volume

418.7K

Market Cap

$229.47M

About Journey Medical Corporation Common Stock

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 41 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$17.63M	$-2,315,000	$-0.09
Q2 2025	$15.01M	$-3,796,000	$-0.16
Q1 2025	$13.14M	$-4,073,000	$-0.18
FY 2024	$56.13M	$-14,672,000	$-0.72

Related Market News

No specific coverage for DERM yet. Check out our latest market news or earnings calendar.

Get DERM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Journey Medical Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.